Jay Berman, MD
Gynecology · Southfield, MINPI 1710924238
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Acessa Health Inc. at 32.8% of the total. Reporting peaked in 2019 at $66,103 and has fallen 87.4% since, to $8,322 in 2025. Among gynecology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $639.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acessa Health Inc.$71K
- Hologic Sales And Service, LLC$36K
- AbbVie$29K
- Lupin Inc.$27K
- Gynesonics, Inc.$17K
- Organon$9K
- plus $29K from 31 others
Across 192 payments — averaging $2038.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sumitomo Pharma America, Inc.$194K
- AbbVie$115K
- Myovant Sciences GmbH$47K
- Myovant Sciences Inc.$23K
- Bayer$10K
- Pfizer$3K
What the payments were for
- Consulting fees$121,14556%
- Speaking & faculty fees$70,59832%
- Travel & lodging$15,0537%
- Food & beverage$11,1465%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acessa Health Inc.(2 entities) | 40 | $71,412 |
| Hologic Sales And Service, LLC | 55 | $36,194 |
| AbbVie(2 entities) | 59 | $29,052 |
| Lupin Inc. | 26 | $26,874 |
| Gynesonics, Inc. | 18 | $16,876 |
| Organon | 17 | $8,583 |
| Merck | 17 | $7,064 |
| Covidien LP | 18 | $5,998 |
| Bayer | 25 | $4,928 |
| Myovant Sciences Inc. | 7 | $4,145 |
| Pfizer | 2 | $2,607 |
| Sumitomo Pharma America, Inc. | 8 | $1,847 |
| Amgen | 6 | $609 |
| Aspira Women's Health Inc | 5 | $363 |
| Lilly USA, LLC | 4 | $278 |
| Astellas Pharma US Inc | 4 | $242 |
| Medtronic | 2 | $181 |
| Medical Device Business Services, Inc. | 1 | $119 |
| Intuitive Surgical | 1 | $99 |
| Coopersurgical, Inc. | 5 | $92 |
| Coloplast | 3 | $45 |
| Mayne Pharma Commercial LLC | 2 | $34 |
| Itamar Medical Inc | 1 | $28 |
| Sage Therapeutics, LLC | 1 | $24 |
| Cytyc Surgical Products, LLC | 1 | $24 |
| Meditrina | 2 | $23 |
| Boston Scientific | 1 | $21 |
| Exact Sciences | 1 | $21 |
| Minerva Surgical, Inc | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Shield Therapeutics Inc | 1 | $19 |
| Channel Medsystems, Inc. | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $18 |
| Gilead | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Medicem Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACESSA PROVU SYSTEM$84,742
- SOLOSEC$26,413
- Orilissa$21,827
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$16,643
- NEXPLANON$15,125
- Acessa$7,155
- ORIAHNN$6,000
- TruClear$5,884
- MYFEMBREE$5,795
- NONE$3,867
- Xofigo$1,750
- Essure$1,750
- EVENITY$481
- Mirena$350
- Kyleena$350
- Skyla$350
- OVA1$282
- ZEPBOUND$246
- MYOSURE TISSUE REMOVAL DEVICE$245
- NovaSure$245
How this compares
$217,942 in reported general payments places this provider in the 95th percentile of 50 gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 47 | $7,902 |
| YuvafemEstradiol | 14 | $3,050 |
| Estradiol (Twice Weekly)Estradiol | 11 | $1,440 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 13 | $1,137 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Southfield
- Lisa CardwellSouthfield$7K
- Michele ThomasSouthfield$6K
- David StoneSouthfield$1K
- George ShadeSouthfield$350
- Donald BlitzSouthfield$160
- John LagrandGrand Rapids$58K
- Noor Dasouki AbualnadiAnn Arbor$47K
- Deborah RussellSaginaw$30K
- Mona FakihDearborn Heights$11K
- Roderick CairgleDetroit$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.